Navigation Links
Data on Telavancin and Micafungin Hold Promise of New Therapeutic,Options in Fight Against Serious Infectious Disease

- Studies Reinforce Astellas Commitment to Overcoming Critical Shortage of New Antimicrobial Agents

MUNICH, Germany, April 02, 2007 /PRNewswire/ --Study results presented at the 17th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) show that the antibiotic telavancin, and the antifungal micafungin, both have the potential to meet a significant unmet need in the fight against serious hospital-acquired infections (HAIs).

Hospital-acquired, or nosocomial infections, are one of the leading causes of death and increased morbidity amongst patients in a hospital setting.(1) Estimates suggest that HAIs cost the UK economy GBP1 billion a year.(2) The greatest contributor to this cost is the increased length of hospital stay for patients with infection.(3),(4),(5)

Telavancin data

Data presented from ATLAS 1 and ATLAS 2, two multinational phase 3 studies, show that telavancin was found to be effective for the treatment of patients with complicated skin and skin structure infections (cSSSIs), including those caused by Gram-positive organisms, including methicillin-resistant Staphylococcus aureus (MRSA).(6),(7)

The results of the two double blind parallel studies, in which 1,867 patients were treated, showed that telavancin compared favorably to standard therapy in clinical cure, microbiological eradication, and overall therapeutic response rates. The safety profile of telavancin in these studies was compatible with treatment of patients with serious infections due to resistant bacteria.

    Astellas Pharma Ltd


    Lovett House, Lovett Road,

    Staines, TW18 3AZ

    Tel: +44(0)1784-419615

    Fax: +44(0)1784-419401

    Astellas Pharma Ltd.

    Registered in England &

    Wales 0787610


Commenting on the study results, investigator Professor M Stryjewski, Duke Clinical Research Institute, Durham, North Carolina, USA said, "Antibio
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial
2. New Drugs in Multinational Study Show Promise in Fighting Drug-Resistant HIV
3. Beike Biotechnology Study Suggests Adult Stem Cells Show Promise for Peripheral Vascular Disease
4. Ceragenix Compound Shows Promise for Treating Lethal Cystic Fibrosis Infections
5. Anti-TNF Golimumab Continues to Show Promise in Phase II Rheumatoid Arthritis Study
6. Trial Results with Intranasal Fentanyl Hold Promise for Treatment of Breakthrough Pain in Cancer
7. Merck at ASCO 2007: Spectrum of Studies Reinforces Promise of Erbitux for Colorectal and Head and Neck Cancer Patients
8. Investigational Drug Cediranib (AZD2171) Shows Promise in Patients With Recurrent Glioblastoma (GBM)
9. RTA 402 Shown to Inhibit STAT3 in Animal Model and Holds Significant Promise for Treating Breast Cancer
10. Alzheimers Drug Shows Promise in Fighting Cancer
11. Neuroblastoma Expert Reviews Progress and Challenges in Fighting Difficult Pediatric Cancer
Post Your Comments:
(Date:5/6/2015)... Calif. , May 6, 2015  Genomic Health, ... Kim Popovits , Chairman of the Board, Chief Executive ... America Merrill Lynch 2015 Healthcare Conference in ... 3:40 p.m. Pacific Time (PT). To access ... go to the  Investor Relations  section of the company,s ...
(Date:5/6/2015)... 6, 2015  Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD ... development and commercialization of a once-daily, oral therapy for ... today that it will host a conference call and ... for the period ended March 31, 2015 and to ... its clinical program for aramchol. Conference ...
(Date:5/6/2015)... May 6, 2015 Neuralstem, Inc. (NYSE MKT: ... to develop small molecule and cell therapy treatments for ... Jonathan Lloyd Jones to the position of Chief ... Mr. Lloyd Jones brings to the ... business development experience.   Most recently, Mr. Lloyd Jones ...
Breaking Medicine Technology:Genomic Health to Present at the Bank of America Merrill Lynch 2015 Healthcare Conference 2Genomic Health to Present at the Bank of America Merrill Lynch 2015 Healthcare Conference 3Galmed Pharmaceuticals First Quarter 2015 Conference Call and Webcast Scheduled for Wednesday, May 13, 2015 2Galmed Pharmaceuticals First Quarter 2015 Conference Call and Webcast Scheduled for Wednesday, May 13, 2015 3Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 2Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 3Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 4
... Novel Biomarkers Displaying 90% Sensitivity in Breast ... ... announced today the,discovery and validation of the most frequent DNA alterations detected ... appeared in PLoS ONE. The study entitled, "Identification of,Novel High-Frequency DNA Methylation ...
... GeoVax Labs, Inc. (OTC,Bulletin Board: GOVX), an Atlanta-based ... has retained Financial,Relations Board (FRB), as its Investor ... HIV-1/AIDS vaccine human trial results need to be,conveyed ... AIDS,pandemic," stated Kathy Waller, co-president of FRB., ...
Cached Medicine Technology:Orion Genomics Announces the Discovery of Novel Breast Cancer Biomarkers 2GeoVax Labs, Inc. Selects Financial Relations Board as Investor Relations Counsel 2GeoVax Labs, Inc. Selects Financial Relations Board as Investor Relations Counsel 3GeoVax Labs, Inc. Selects Financial Relations Board as Investor Relations Counsel 4
(Date:5/6/2015)... (PRWEB) May 06, 2015 Established by ... wellness for the estimated 46 million Americans who suffer ... upon monthly medications to alleviate their symptoms. Medicationdiscountcard.com is ... to save patients money on the costs of these ... are used to treat the pain and inflammation in ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 The American ... nomination period for its prestigious Integrated Water Resources Management ... IWRM approach to water resources projects. , An IWRM approach ... our establishment in 1964. In 2014, 12 projects were nominated ... IMPACT magazine features not only the 2014 AWRA IWRM Award ...
(Date:5/6/2015)... Wethersfield, Conn. (PRWEB) May 06, 2015 ... company in Wethersfield, Conn., has hired healthcare executive ... vice president. Olson will lead Qualidigm’s growing ... further Qualidigm’s mission to improve the quality, safety, ... Olson comes to Qualidigm from Interim HealthCare of ...
(Date:5/6/2015)... 2015 Novodiax announced today that ... of Innovations with Ed Begley Jr., airing via ... times TBA. , This segment will explore Novodiax, ... diagnostics. Audiences will learn about Novodiax’s polymer detection ... behind the scenes to investigate how, based on ...
(Date:5/6/2015)... The Center for Innovative Technology (CIT) announced ... e-Kare, Inc. of Fairfax, VA, a digital health company ... wounds. , Chronic wounds include pressure, venous, and diabetic ... over 6.5 million U.S. patients, costing over $25 billion. ... the Children’s National Medical Center (CNMC), e-Kare ...
Breaking Medicine News(10 mins):Health News:Medicationdiscountcard.com Provides Access to Drug Coupons for Arthritis Awareness Month 2Health News:Medicationdiscountcard.com Provides Access to Drug Coupons for Arthritis Awareness Month 3Health News:Nominations Sought for Integrated Water Resources Management (IWRM) Award 2Health News:Innovative Healthcare Executive Ann Olson Joins Qualidigm as Principal and Vice President 2Health News:Innovative Healthcare Executive Ann Olson Joins Qualidigm as Principal and Vice President 3Health News:Novodiax to Be Featured in Upcoming Episode of Innovations TV Series 2Health News:CIT GAP Funds Invests in e-Kare 2Health News:CIT GAP Funds Invests in e-Kare 3
... Clearly Contacts, the ... BC Business Magazines, Top 100 Public Companies list for the fifth consecutive year. Clearly ... with revenue of $119 million for fiscal 2008. , ... Vancouver, British Columbia (Vocus) June 30, 2009 -- Clearly Contacts ...
... ... editor-in-chief of Orthopaedic Knowledge Online, William A. Grana, MD, MPH, will be inducted into ... July 11th during its Annual Meeting in Keystone, Colorado. , ... Keystone, CO (Vocus) June 30, 2009 ...
... Limited (Chiltern), a global clinical research organization (CRO) announced that ... , , Dr. Attila Lorinczi will lead ... Medical Society and the Society of Hungarian Urologists. Dr. Lorinczi ... years, most recently as a clinical operations manager. , ...
... Oxford University Press is proud to present the ... AMA Manual of Style, the "bible" ... involved in medical or scientific publishing. Because scientific, medical, and ... a new treatment hinges on how well the evidence to ...
... , MINNEAPOLIS, June 29 HealthFitness Corporation (NYSE ... employee health and productivity management solutions, announced today that the ... the close of market on June 26, 2009, when Russell ... indexes. , , About HealthFitness , ...
... in doctor,s office, for example, at risk, study shows , ... blood pressure that can happen in a doctor,s office, or ... sustained high blood pressure, a new study finds. , Researchers ... In white-coat hypertension, a patient,s blood pressure is high while ...
Cached Medicine News:Health News:Clearly Contacts Named to BC Business Magazine Top 100 Public Companies List 2Health News:Teacher and Profession Leader, William A. Grana, MD, MPH, Inducted into Sports Medicine Hall of Fame 2Health News:Teacher and Profession Leader, William A. Grana, MD, MPH, Inducted into Sports Medicine Hall of Fame 3Health News:Chiltern Opens Office in Budapest, Hungary 2Health News:AMA Manual of Style, the 'Bible' for Medical and Scientific Publishing, Gains Online Presence 2Health News:HealthFitness Added to the Russell Microcap Index 2Health News:Sporadic Spikes in Blood Pressure Hike Chances of Hypertension 2
Duckbill type, sharp. 3 mm x 8 mm curved blade. Octagonal handle....
10 mm wide tip....
9 mm wide tip. 35 mm from angle to tip....
Designated most popular model or size. 4 mm wide tip....
Medicine Products: